4//SEC Filing
Tullman Stephen A. 4
Accession 0001209191-18-054397
CIK 0001557746other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:37 PM ET
Size
6.1 KB
Accession
0001209191-18-054397
Insider Transaction Report
Form 4
Tullman Stephen A.
Director
Transactions
- Purchase
Common Stock
2018-10-04$14.00/sh+7,100$99,370→ 177,457 total
Holdings
- 394,014(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the record holder of the securities on March 23, 2018.
- [F2]This transaction was executed in multiple trades at prices ranging from $13.90 to $14.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]These shares are held by the 2007 Irrevocable Trust of Stephen A. Tullman, for which the reporting person's spouse serves as the trustee.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654343
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:37 PM ET
- Size
- 6.1 KB